关注
Catherine Koch
Catherine Koch
MD-PhD Student Harvard Medical School and Massachusetts Institute of Technology
在 mit.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress
PM Bruno, Y Liu, GY Park, J Murai, CE Koch, TJ Eisen, JR Pritchard, ...
Nature medicine 23 (4), 461-471, 2017
4912017
MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors
K Birsoy, T Wang, R Possemato, OH Yilmaz, CE Koch, WW Chen, ...
Nature genetics 45 (1), 104-108, 2013
2772013
Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains
KS Gordon, T Kyung, CR Perez, PV Holec, A Ramos, AQ Zhang, ...
Nature biomedical engineering 6 (7), 855-866, 2022
362022
The Lgr5 transgene is expressed specifically in glycinergic amacrine cells in the mouse retina
K Sukhdeo, CE Koch, TE Miller, H Zhou, M Rivera, K Yan, CL Cepko, ...
Experimental eye research 119, 106-110, 2014
232014
Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screening
A Ramos, CE Koch, Y Liu-Lupo, RD Hellinger, T Kyung, KL Abbott, ...
Nature Communications 14 (1), 8048, 2023
72023
Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer
R Carter, A Cheraghchi-Bashi, A Westhorpe, S Yu, Y Shanneik, E Seraia, ...
Cancer Biology & Medicine 16 (2), 234, 2019
72019
CARPOOL: A library-based platform to rapidly identify next generation chimeric antigen receptors
T Kyung, KS Gordon, CR Perez, PV Holec, A Ramos, AQ Zhang, Y Liu, ...
bioRxiv, 2021.07. 09.450900, 2021
32021
Abstract PR-003: In vivo genome-wide CRISPR/Cas9 screens conducted in an immunocompetent mouse model of glioblastoma identify novel in vivo tumor …
CE Koch, CA Whittaker, MT Hemann
Cancer Research 84 (5_Supplement_1), PR-003-PR-003, 2024
2024
Utilizing in vivo genome-wide CRISPR/Cas9 screens in immunocompetent mouse models to identify novel tumor liabilities and explore mechanisms of resistance to Chimeric Antigen …
CE Koch
Massachusetts Institute of Technology, 2024
2024
Author Correction: Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains
KS Gordon, T Kyung, CR Perez, PV Holec, A Ramos, AQ Zhang, ...
Nature Biomedical Engineering 7 (4), 599-602, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–10